WebIonis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has 3 commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen) and has 4 drugs in pivotal studies: tominersen for Huntington’s disease, tofersen for SOD1 … Web2 apr. 2024 · Ionis Pharmaceuticals, Inc. Common Stock (IONS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
IONS Stock Forecast — Price Target for 2024 — TradingView
Web3 dec. 2024 · Ionis Pharmaceuticals stock dropped 14% on 10/18/2024, compared to broader market (S&P500) rise of 0.3% A change of -14% or more over one trading day is … WebCompany. Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on cardiovascular and neurology franchises. The Company’s products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for the treatment of patients with spinal muscular atrophy … howes truss
Ionis Pharmaceuticals - IONS - Stock Price Today - Zacks
WebIonis Pharmaceuticals (IONS) Stock Chart & Technical Analysis Graph. Follow. 1,093 Followers. Portfolio. Ionis Pharmaceuticals's advanced charting and technical analysis … WebIonis Pharmaceuticals live price charts and stock performance over time. ... IONS Ionis Pharmaceuticals . 33.95 0.01 (0.03%) Delayed Prices By NASDAQ, in USD Market … WebIONS Interactive Stock Chart Ionis Pharmaceuticals, Inc. Stock - Yahoo Finance Back Try the new and improved charts Ionis Pharmaceuticals, Inc. (IONS) NasdaqGS - … howe street chicago